Patent Assignment
Reel/Frame 058886/0687
Change of Name
Recorded: 2022-01-27
Pages: 3
Assignor
BIOGEN HEMOPHILIA INC.
Executed: 2016-09-01
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property
(1)
Factor Viii-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.